CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and software solutions, today announced that fiscal 2009 revenues were $385.2 million, compared to fiscal 2008 revenues of $398.0 million, a decline of 3%. Revenue results reflected a negative foreign exchange impact of nearly $12 million compared to fiscal 2008. The results include approximately $6.9 million of revenue derived from our new Temperature Management business, whose assets were acquired from Alsius Corporation in May 2009. Net income for the year was $9.6 million, compared to $23.4 million in the prior year. Diluted earnings per share were $0.45, compared to $1.10 in the prior year. Backlog at the end of the year was approximately $19.7 million, as compared to $7.9 million at the end of the prior fiscal year and $9.8 million at the end of Q3 2009.
